Biohaven Ltd. (BHVN) Stock Price, News, Quote & History

82.57. -1.16%. RYTM Rhythm Pharmaceuticals, Inc. 47.08. -1.34%. Find the latest Biohaven Ltd. (BHVN) stock quote, history, news and other vital information to help you with your stock …

CouponFollow Extension

16%
OFF

Biohaven Ltd. (BHVN) Stock Price, News, Quote & History

1 week from now

82.57. -1.16%. RYTM Rhythm Pharmaceuticals, Inc. 47.08. -1.34%. Find the latest Biohaven Ltd. (BHVN) stock quote, history, news and other vital information to help you with your stock …

yahoo.com

$150
OFF

BHVN Stock Price | Biohaven Ltd. Stock Quote (U.S.: NYSE)

1 week from now

6 days ago · Biohaven Pharmaceutical stock price target raised to $150 from $101 at BMO Capital. Aug. 3, 2021 at 9:20 a.m. ET by Tomi Kilgore.

marketwatch.com

$59
OFF

Biohaven Pharmaceutical Holding Co Ltd Stock Price Today | NYSE: …

1 week from now

Biohaven maintains Buy rating with $59 target amid SMA trial optimism. On Monday, Biohaven Pharmaceutical Holding (NYSE:BHVN) sustained a Buy rating and a price target of $59.00, as …

investing.com

$53.47
OFF

Biohaven Stock Price Today (NYSE: BHVN) Quote, Market Cap, …

1 week from now

Nov 8, 2024 · How much is Biohaven stock worth today? (NYSE: BHVN) Biohaven currently has 94,542,253 outstanding shares. With Biohaven stock trading at $53.47 per share, the total …

wallstreetzen.com

8%
OFF

Biohaven (NYSE:BHVN) Shares Down 8% - Here's What Happened

1 week from now

1 day ago · Biohaven Ltd. (NYSE:BHVN - Get Free Report)'s share price was down 8% on Friday . The stock traded as low as $44.68 and last traded at $44.76. Approximately 542,438 shares …

marketbeat.com

$44.39
OFF

Biohaven Ltd. (NYSE:BHVN) Shares Purchased By US Bancorp DE

1 week from now

8 hours ago · Get Our Latest Report on Biohaven. Biohaven Trading Down 8.8 %. NYSE:BHVN opened at $44.39 on Friday. Biohaven Ltd. has a 1 year low of $26.80 and a 1 year high of …

defenseworld.net

$63.42
OFF

Royal Bank Of Canada Issues Pessimistic Forecast For Biohaven …

1 week from now

3 days ago · According to data from MarketBeat, Biohaven currently has an average rating of "Buy" and a consensus target price of $63.42. Get Our Latest Stock Report on BHVN. …

marketbeat.com

$69.00
OFF

Biohaven Ltd. (BHVN) Receives A Buy From Morgan Stanley

1 week from now

2 days ago · In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on Biohaven Ltd. (BHVN – Research Report), with a price target of $69.00. The …

businessinsider.com

FAQs about Biohaven Ltd. (BHVN) Stock Price, News, Quote & History Coupon?

What does bhvn stand for?

Find the latest Biohaven Ltd. (BHVN) stock quote, history, news and other vital information to help you with your stock trading and investing. ...

Is Biohaven Ltd (bhvn) a good stock to buy?

If you are looking for stocks that are well positioned to maintain their recent uptrend, Biohaven Ltd. (BHVN) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen. Are Medical Stocks Lagging Biohaven Ltd. (BHVN) This Year? ...

Is bhvn a good stock to buy?

BHVN is trading within a range we consider fairly valued. Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. ...

Where is Biohaven Ltd headquartered?

The company was founded on May 2, 2022 and is headquartered in New Haven, CT. View Biohaven Ltd. BHVN stock quote prices, financial information, real-time forecasts, and company news from CNN. ...

Why did Biohaven (bhvn) shares surge?

Biohaven (BHVN) shares surged after the company's troriluzole drug showed significant slowed progression of spinocerebellar ataxia, a rare neurological disease. George Tsilis shares how the promising ... ...

Why did Biohaven stock rise 137% on Sept 23?

Shares of Biohaven Ltd. BHVN were up 13.7% on Sept. 23 after the company announced positive top-line data from the pivotal BHV4157-206-RWE study, which evaluated its pipeline candidate, troriluzole, for... Biohaven Stock Soars on Drug Trial Results: Time to Jump In? MarketBeat - Tue Sep 24, 9:42AM CDT ...